Allopurinol and xanthine oxidase inhibition in liver ischemia reperfusion

Journal of Hepato-Biliary-Pancreatic Sciences

Volumn 18, Issue 2, 2011, Pages 137-146

  Peglow, Stephanie ^a   Toledo, Alexander H ^b   Anaya Prado, Roberto ^c   Lopez Neblina, Fernando ^d   Toledo Pereyra, Luis H ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^d UNIVERSIDAD AUTÓNOMA DE BAJA CALIFORNIA   (Mexico)

Author keywords

Allopurinol; Ischemia reperfusion injury; Liver ischemia; Reactive oxygen species; Xanthine oxidase inhibition

Indexed keywords

ALANINE AMINOTRANSFERASE; ALLOPURINOL; ASPARTATE AMINOTRANSFERASE; LACTATE DEHYDROGENASE; MERCAPTOPURINE; NICOTINAMIDE ADENINE DINUCLEOTIDE; REACTIVE OXYGEN METABOLITE; XANTHINE DEHYDROGENASE; XANTHINE OXIDASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; DRUG STRUCTURE; ENZYME INHIBITION; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER INJURY; LIVER ISCHEMIA; LIVER PROTECTION; MITOCHONDRIAL MEMBRANE; NONHUMAN; OXIDATIVE STRESS; PROTEIN SYNTHESIS; REPERFUSION INJURY; REVIEW; RNA SYNTHESIS; SIGNAL TRANSDUCTION;

EID: 85027935384     PISSN: 18686974     EISSN: 18686982     Source Type: Journal    
DOI: 10.1007/s00534-010-0328-7     Document Type: Review

References (56)

1. DeWall RA, Vasko KA, Stanley EL, Kezdi P. Responses of the ischemic myocardium to allopurinol. Am Heart J. 1971;82:362-70.
2. Crowell JW, Jones CE, Smith EE. Effect of allopurinol on hemorrhagic shock. Am J Physiol. 1969;216:744-8.
3. Siems W, Mielke B, Müller M, Heumann C, Räder L, Gerber G. Status of glutathione in the rat liver. Enhanced formation of oxygen radicals at low oxygen tension. Biomed Biochim Acta. 1983;42:1079-89.
4. Nordström G, Seeman T, Hasselgren PO. Beneficial effect of allopurinol in liver ischemia. Surgery. 1985;97:679-84. (Pubitemid 16163133)
5. Metzger J, Lauterburg BH. Effect of allopurinol on oxidant stress and hepatic function following ischemia and reperfusion in the rat. Liver. 1988;8:344-9. (Pubitemid 19025361)
6. Toledo-Pereyra LH, Cederna J, Choudhury S. Oxygen free radicals, allopurinol and the xanthine oxidase pathway during liver ischemia. Surg Res Commun. 1989;5:297-307. (Pubitemid 19121087)
7. Lee WY, Lee SM. Synergistic protective effect of ischemic preconditioning and allopurinol on ischemia/reperfusion injury in rat liver. Biochem Biophys Res Commun. 2006;349:1087-93.
8. Liu PG, He SQ, Zhang YH, Wu J. Protective effects of apocynin and allopurinol on ischemia/reperfusion-induced liver injury in mice. World J Gastroenterol. 2008;14:2832-7.
9. Taha MO, Simões MJ, Noguerol EC, et al. Effects of allopurinol on ischemia and reperfusion in rabbit livers. Transplant Proc. 2009;41:820-3.
10. Jeon BR, Yeom DH, Lee SM. Protective effect of allopurinol on hepatic energy metabolism in ischemic and reperfused rat liver. Shock. 2001;15:112-7.
11. Karwinski W, Søreide O. Allopurinol improves scavenging ability of the liver after ischemia/reperfusion injury. Liver. 1997;17:139-43. (Pubitemid 27363865)
12. Durmuş O, Aricioǧlu A, Güven T, Oǧuz M, Yel M, Türközkan N. The effect of allopurinol on the liver ultrastructure, reduced glutathione and lipid peroxide levels during liver ischemia in guinea pigs. Gen Pharmacol. 1994;25:781-6. (Pubitemid 24225011)
13. Nauta RJ, Tsimoyiannis E, Uribe M, Walsh DB, Miller D, Butterfield A. Oxygen-derived free radicals in hepatic ischemia and reperfusion injury in the rat. Surg Gynecol Obstet. 1990;171:120-5. (Pubitemid 20286831)
14. Karwinski W, Drange A, Farstad M, Ulvik R, Søreide O. 60 min normothermic liver ischemia in rats: allopurinol improves energy status and bile flow during reperfusion. Eur Surg Res. 1990;22:27-33. (Pubitemid 20181312)
15. Rundles RW. The development of allopurinol. Arch Intern Med. 1985;145:1492-503.
16. Nobel Prize. 2010. http://nobelprize.org. Accessed 26 Jan 2010.
17. Product Information. 2000. Zyloprim, allopurinol. Bedminster: Faro Pharmaceuticals (PI revised 2/99). Reviewed Feb 2000.
18. AHFS Drug information. 1999. Bethesda: American Society of Hospital Pharmacists; 1999. pp. 3221-3224.
19. Product Information. 1999. Aloprim, allopurinol sodium for injection. Boca Raton: Nabi (PI revised 6/99). Reviewed Feb 2000.
20. Vasko KA, DeWall RA, Riley AM. Effect of allopurinol in renal ischemia. Surgery. 1972;71:787-90.
21. Toledo-Pereyra LH, Najarian JS. Total recovery of ischemic kidneys treated with allopurinol before transplantation. Surg Forum. 1973;24:302-4.
22. Lazarus HM, Owens ML, Hopfenbeck A. Allopurinol protection of hepatic nuclear function during hemorrhagic shock. Surg Forum. 1974;25:10-2.
23. Toledo-Pereyra LH, Simmons RL, Najarian JS. Protection of the ischemic liver by donor pretreatment before transplantation. Am J Surg. 1975;129:513-7.
24. McCord JM, Fridovich I. The reduction of cytochrome c by milk xanthine oxidase. J Biol Chem. 1968;243:5753-60.
25. Granger DN, Rutilli G, McCord JM. Superoxide radicals in feline intestinal ischemia. Gastroenterology. 1981;81:22-9. (Pubitemid 11078477)
26. Jaeschk H. Role of reactive oxygen species in hepatic ischemia-reperfusion injury and preconditioning. J Invest Surg. 2003;16:127-40.
27. Southard JH, Marsh DC, McAnulty JF, Belzer FO. Oxygen-derived free radical damage in organ preservation: activity of superoxide dismutase and xanthine oxidase. Surgery. 1987;101:566-70. (Pubitemid 17076094)
28. Kamiike W, Watanabe F, Hashimoto T, et al. Changes in cellular levels of ATP and its catabolites in ischemic rat liver. J Biochem. 1982;91:1349-56. (Pubitemid 12021133)
29. Karwinski W, Farstad M, Ulvik R, Søreide O. Sixty-minute normothermic liver ischemia in rats. Evidence that allopurinol improves liver cell energy metabolism during reperfusion but that timing of drug administration is important. Transplantation. 1991;52:231-4.
30. Atalla SL, Toledo-Pereyra LH, MacKenzie GH, Cederna JP. Influence of oxygen-derived free radical scavengers on ischemic livers. Transplantation. 1985;40:584-90. (Pubitemid 16207179)
31. McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med. 1985;312:159-63. (Pubitemid 15192863)
32. Stripe F, Della Corte E. The regulation of rat liver xanthine oxidase. Conversion in vitro of the enzyme activity from dehydrogenase (type D) to oxidase (type O). J Biol Chem. 1969;244:3855-63.
33. Engerson TD, McKelvey TG, Phyne DB, Boggion EB, Snyder SJ, Jones HP. Conversion of xanthine dehydrogenase to oxidase in ischemic rat tissues. J Clin Invest. 1987;79:1564-70. (Pubitemid 17117257)
34. Greenwalk RA, Cohen G, editors. Oxygen radicals and their scavenger systems. Cellular and medical aspects. New York: Elsevier; 1983.
35. Jaeschke H. Glutathione disulfide formation and oxidant stress during acetaminophen-induced hepatotoxicity in mice in vivo: the protective effect of allopurinol. J Pharmacol Exp Ther. 1990;255:935-41.
36. Godin DV, Bhimji S. Effects of allopurinol on myocardial ischemic injury induced by coronary artery ligation and reperfusion. Biochem Pharmacol. 1987;36:2101-7. (Pubitemid 17101721)
37. Karwinski W, Ulvik R, Farstad M, Svardal A, Berge R, Søreide O. Effect of allopurinol on the concentration of endogenous glutathione in hepatocytes after an hour of normothermic liver ischemia. Eur J Surg. 1993;159:355-9. (Pubitemid 23205772)
38. Moorhouse PC, Grootveld M, Halliwell B, Quinlan JG, Gutteridge JM. Allopurinol and oxypurinol are hydroxyl radical scavengers. FEBS Lett. 1987;213:23-8. (Pubitemid 17036125)
39. Peterson DA, Kelly B, Gerrard JM. Allopurinol can act as an electron transfer agent. Is this relevant during reperfusion injury? Biochem Biophys Res Commun. 1986;137:76-9.
40. Castillo M, Toledo-Pereyra LH, Prough D, Sharpiro E, Gordon D, Choudhury S. Effective timing of allopurinol administration in the ischemic liver. Transplantation. 1989;47:727-30. (Pubitemid 19110939)
41. Rhoden E, Pereira-Lima L, Lucas M, et al. The effects of allopurinol in hepatic ischemia and reperfusion: experimental study in rats. Eur Surg Res. 2000;32:215-22.
42. Yildirim S, Tok H, Köksal H, Erdem L, Baykan A. Allopurinol plus pentoxifilline in hepatic ischaemia/reperfusion injury. Asian J Surg. 2002;25:149-53. (Pubitemid 34595857)
43. Adkison D, Höllwarth ME, Benoit JN, Parks DA, McCord JM, Granger DN. Role of free radicals in ischemia-reperfusion injury to the liver. Acta Physiol Scand Suppl. 1986;548:101-7. (Pubitemid 16090302)
44. Metzger J, Dore SP, Lauterburg BH. Oxidant stress during reperfusion of ischemic liver: no evidence for a role of xanthine oxidase. Hepatology. 1988;8:580-4.
45. Lu P, Liu F, Yao Z, et al. Nitrite-derived nitric oxide by xanthine oxidoreductase protects the liver against ischemia-reperfusion injury. Hepatobiliary Pancreat Dis Int. 2005;4:350-5. (Pubitemid 41207532)
46. Schauer RJ, Bilzer M, Kalmuk S, et al. Microcirculatory failure after rat liver transplantation is related to Kupffer cell-derived oxidant stress but not involved in early graft dysfunction. Transplantation. 2001;72:1692-9. (Pubitemid 33096749)
47. Jaeschke H, Farhood A. Neutrophil and Kupffer cell-induced oxidant stress and ischemia-reperfusion injury in rat liver. Am J Physiol. 1991;260:G355-62.
48. Caraceni P, Ryu HS, van Thiel DH, Borle AB. Source of oxygen free radicals produced by rat hepatocytes during postanoxic reoxygenation. Biochim Biophys Acta. 1995;1268:249-54.
49. Adams JD Jr, Lauterburg BH, Mitchell JR. Plasma glutathione and glutathione disulfide in the rat: regulation and response to oxidative stress. J Pharmacol Exp Ther. 1983;227:749-54. (Pubitemid 14215063)
50. Lauterburg BH, Smith CV, Hughes H, Mitchell JR. Biliary excretion of glutathione and glutathione disulfide in the rat. Regulation and response to oxidative stress. J Clin Invest. 1984;73:124-33. (Pubitemid 14222655)
51. Vriens MR, Marinelli A, Harinck HI, Zwinderman KH, van de Velde CJ. The role of allopurinol in human liver ischemia/ reperfusion injury: a prospective randomized clinical trial. Hepatogastroenterology. 2002;49:1069-73. (Pubitemid 34809789)
52. Karwinski W, Farstad M, Ulvik R, Sreide O. Sixty minutes normothermic ischemia in rat liver: the declining tissue concentration of hypoxanthine during reperfusion is not a washout phenomenon. Eur Surg Res. 1992;24:257-64.
53. Matsui N, Satsuki I, Morita Y, et al. Xanthine oxidase-derived reactive oxygen species activate nuclear factor kappa B during hepatic ischemia in rats. Jpn J Pharmacol. 2000;84:363-6. (Pubitemid 32000466)
54. Tsung A, Sahai R, Tanaka H, et al. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med. 2005;7:1135-43. (Pubitemid 40524681)
55. Kupcsulik P, Kokas P. Ischemic damage of the liver. Part I: In vitro investigation of the prevention of the ischemic lesion of the liver. Acta Hepatogastroenterol (Stuttg). 1979;26:279-83.
56. Kupcsulik P, Kokas P. Ischemic damage of the liver. Part II: In vivo investigation of the prevention of the ischemic lesion of the liver. Acta Hepatogastroenterol (Stuttg). 1979;26:284-9.